Problem 10 - Clinical Chemistry

Question

The preferred screening test for diabetes in nonpregnant adults is measurement of a. Fasting plasma glucose b. 2 hour postprandial c. Glycohemoglobin d. No one test is preferred over another for diagnosis

Step-by-Step Solution

Answer

The preferred screening test for diabetes in nonpregnant adults is the Fasting Plasma Glucose (FPG) test.

Step 1: Understand the Question

The question asks for the preferred screening test for diabetes in nonpregnant adults. Screening tests are used to identify individuals who might have the disease but do not currently show any symptoms.

Step 2: Identify the Options

The options provided are:a. Fasting plasma glucose (FPG)b. 2 hour postprandiald. Glycohemoglobine. No one test is preferred over another for diagnosis

Step 3: Know the Preferred Screening Test

For nonpregnant adults, the American Diabetes Association (ADA) recommends Fasting Plasma Glucose (FPG) as the preferred screening test. This test measures blood sugar levels after an overnight fast and helps to identify individuals with prediabetes or diabetes.

Step 4: Evaluate the Other Options

The 2-hour postprandial test measures blood sugar levels two hours after eating but is not typically used as a screening test. Glycohemoglobin, also known as HbA1c, is used to monitor long-term glucose control rather than for initial screening. Finally, the statement that no one test is preferred over another contradicts the ADA guidelines.

Step 5: Conclude the Answer

Based on ADA guidelines and typical medical practice, the preferred screening test for diabetes in nonpregnant adults is the Fasting Plasma Glucose test.

Key Concepts

Fasting Plasma Glucose

Screening for diabetes in nonpregnant adults often begins with the fasting plasma glucose (FPG) test. This test requires an individual to fast overnight for at least 8 hours before having their blood sugar level measured.
FPG is particularly useful because it is simple and provides a quick snapshot of how the body manages glucose over a fasting period.

• A normal FPG result is less than 100 mg/dL.
• Levels between 100-125 mg/dL indicate prediabetes.
• Levels 126 mg/dL or higher on two separate tests indicate diabetes.

By distinguishing between these ranges, doctors can identify individuals at risk of developing diabetes and those who already have the disease.

2-Hour Postprandial Glucose Test

The 2-hour postprandial glucose test measures blood sugar levels exactly two hours after a meal.
This test helps to understand how the body responds to glucose from food.
Although not typically used as a primary screening tool as per the American Diabetes Association guidelines, it can provide additional information in certain cases.

• In a normal response, blood glucose levels should be less than 140 mg/dL after two hours.
• Levels between 140-199 mg/dL suggest prediabetes.
• Levels of 200 mg/dL or higher indicate diabetes.

This test is sometimes used when FPG or HbA1c results are inconclusive.

Glycohemoglobin (HbA1c)

Glycohemoglobin, commonly known as HbA1c, is a crucial measure for long-term glucose control.
It reflects the average blood glucose levels over the past two to three months.
Doctors use HbA1c to monitor the effectiveness of diabetes treatment.

• An HbA1c level below 5.7% is considered normal.
• Levels from 5.7% to 6.4% indicate prediabetes.
• Levels of 6.5% or higher on two separate tests suggest diabetes.

Unlike FPG, HbA1c does not require fasting and shows how well blood sugar has been controlled over a longer period.

American Diabetes Association Guidelines

The American Diabetes Association (ADA) provides guidelines for screening and diagnosing diabetes. These guidelines help ensure consistent and accurate diagnosis and management.
The ADA currently recommends Fasting Plasma Glucose (FPG) or HbA1c tests for diabetes screening in nonpregnant adults.

• FPG is preferred for its accuracy and ease of administration.
• HbA1c is useful for its ability to reflect long-term glucose levels.

By following these guidelines, healthcare providers can identify and treat diabetes early, improving patient outcomes and preventing complications.